All terms in BAO
| Label | Id | Description |
|---|---|---|
| gene overexpression by transient transfection | BAO_0002444 | |
| HL-60 cell | CLO_0003775 | |
| neonatal thyrotoxicosis | DOID_12573 | |
| thyrotoxicosis | DOID_7997 | [A thyroid gland disease that is characterized by excess thyroid hormone.] |
| appendiceal neoplasm | DOID_11240 | |
| FDA-approved compound library | BAO_0700004 | [Any compound library consisting solely of small molecules that have been approved by the FDA. Often used for 'drug re-purposing' assays. The specific compounds included in any given FDA-approved compound library may differ based on availability or timing.] |
| vitamin K deficiency hemorrhagic disease | DOID_11249 | |
| bivalent small molecule-peptide | BAO_0700003 | [A synthetic ligand consisting of a small molecule tethered (covalently or non-covalently) to a peptide.] |
| disseminated intravascular coagulation | DOID_11247 | |
| urethral obstruction | DOID_12577 | |
| MTT reduction assay | BAO_0002457 | [The MTT assay is a colorimetric assay that relies on the enzymatic reduction of a yellow tetrazolium salt, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), which forms a purple formazan crystal in metabolically active cells. The formazan can then be solubilized producing a concentration dependent colorimetric signal at 570 nm proportional to the cell number and activity.] |
| XTT reduction assay | BAO_0002458 | [The XTT Cell Proliferation Assay is a colorimetric assay system which measures the reduction of a tetrazolium component (XTT) into soluble formazan product by the mitochondria of viable cells. The samples are read using an ELISA plate reader at a wavelength of 450nm. The amount of color produced is directly proportional to the number of viable cells.] |
| resazurin reduction assay | BAO_0002459 | [For spectrophotometric measurement of metabolic activity of living cells. Absorbance of converted dye is measured at a wavelength of 600 nm. Bioreduction of the dye reduces the amount of its oxidized form (blue) and concomitantly increases the fluorescent intermediate (red).] |
| beta-adrenergic receptor activity | GO_0004939 | [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors; the activity involves transmitting the signal to the Gs alpha subunit of a heterotrimeric G protein.] |
| functionality | PATO_0001509 | [A quality of a single physical entity that arises by virtue of whether the bearer exhibits the ability to perform a regular function(s).] |
| ER-associated misfolded protein catabolic process | GO_0071712 | [The chemical reactions and pathways resulting in the breakdown of misfolded proteins transported from the endoplasmic reticulum and targeted to cytoplasmic proteasomes for degradation.] |
| nucleic acid amplification method | BAO_0002450 | [A method that uses purified enzymes to isolate and then replicate specific nucleic acids to levels where they can be detected. Examples are PCR, TMA, NASBA, etc.] |
| progesterone receptor agonist | CHEBI_70709 | |
| chromosome mapping | BAO_0002451 | [Mapping is the construction of a series of chromosome descriptions that depict the position and spacing of unique, identifiable biochemical landmarks, including some genes, that occur on the DNA of chromosomes.] |
| volumetric titration | BAO_0002454 | [Method in which the amount of a substance is determined by measuring the volume of a second substance that combines or reacts with the first in known proportions.] |